SurgLine International, Inc.
SGLN · OTC
7/31/2012 | 4/30/2012 | 1/31/2012 | 10/31/2011 | |
|---|---|---|---|---|
| Revenue | -$0 | $0 | $0 | $0 |
| % Growth | -134.6% | -42.6% | -63% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | 231.2% | 63.5% | 21.2% | 47.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $2 |
| SG&A Expenses | $0 | $0 | $0 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $2 |
| Operating Income | -$0 | -$0 | -$0 | -$2 |
| % Margin | 2,541.4% | -324.6% | -539.6% | -2,310.2% |
| Other Income/Exp. Net | $0 | $0 | $0 | $2 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$1 | -$2 |
| % Margin | 4,597.8% | -1,078.2% | -1,827.9% | -2,392.3% |
| EPS | -0 | -0 | -0 | -0.01 |
| % Growth | -47.5% | 67.7% | 99% | – |
| EPS Diluted | -0 | -0 | -0 | -0.01 |
| Weighted Avg Shares Out | 5,347 | 5,347 | 5,818 | 4,994 |
| Weighted Avg Shares Out Dil | 5,347 | 5,347 | 5,818 | 4,994 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | -$0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$0 | -$0 | -$2 |
| % Margin | 9,387.7% | -296.1% | -527.4% | -2,302.4% |